Home > Boards > US OTC > Cannabis > Demand Brands Inc. (DMAN)

Demand Brands, Inc. (OTCPK:DMAN),

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
cuckoo 4 cocoa puffs Member Profile
Followed By 17
Posts 2,309
Boards Moderated 6
Alias Born 08/18/17
160x600 placeholder
cuckoo 4 cocoa puffs   Wednesday, 12/26/18 01:39:23 PM
Re: captainscotty post# 91332
Post # of 98589 
Demand Brands, Inc. (OTCPK:DMAN),
(“Company” or “DMAN”), a collection of brands and businesses promoting healthy lifestyles, operating in the Health and Wellness, Cannabis Edibles, Hemp and CBD industries
http://www.demandbrandsinc.com is pleased to report that the anticipated, soon to be law H.R.
2 Agricultural Improvement Act of 2018, known as the “Farm Bill” that will reclassify the use of
hemp for commercial uses, will allow the Company to significantly accelerate its development,
production and distribution of its product line and will generally, positively impact the
Company’s business: https://www.livetradingnews.com/us-hemp-market-set-to-boom- 116724.html#.XBphoMbrthF The Farm Bill includes a provision involving industrial hemp and its
derivative, cannabidiol CBD effectively removing CBD from the Controlled Substances Act
Scheduling placing it now under the supervision of the Department of Agriculture.
Bruce Hannan, CEO of Demand Brands Inc., commented, “For the Demand Brands products, the
importance and future of this news cannot be understated. This approval from the Senate and
the House and the signing of the 2018 Farm Bill into law will bring an end to the legal grey area
that has limited the production and distribution of some profoundly beneficial substances. For
the industrial hemp market it will enable seed to sale marketing of all industrial hemp products,
just like any other agricultural commodity. This should be a huge win for the economy, the
Company, and the entire hemp industry. Our Infusional and MigrapureH brands will be able now
to complete development and go into production and we expect to begin roll-out in early 2019
targeting niche markets through upcoming expos and trade shows and by tapping the extensive
database of health care clinics within the sector. The Company also intends to accelerate its
existing JV arrangements for products in the US”.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist